Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemoradiation vs GEMOX in Biliary Tract Cancer
NCT00304135Phase 3Completed
- Sponsor
- Fédération Francophone de Cancérologie Digestive
- Start
- Oct 2005
- Primary completion
- Dec 2012
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine, oxaliplatin in biliary tract cancer (BTC), sponsored by Fédération Francophone de Cancérologie Digestive. Started Oct 2005; status: completed.
02
Drugs
gemcitabineoxaliplatin
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT00304135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00304135.